🇺🇸 FDA
Pipeline program

Umbilical Cord Mesenchymal Stem Cells

IT-UCMSC-LCSCI

Phase 2 small_molecule active

Quick answer

Umbilical Cord Mesenchymal Stem Cells for Spinal Cord Injuries is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Spinal Cord Injuries
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials